Related references
Note: Only part of the references are listed.Navitoclax augments the activity of carboplatin and paclitaxel combinations in ovarian cancer cells
Vasileios A. Stamelos et al.
GYNECOLOGIC ONCOLOGY (2013)
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
Maria Vinci et al.
BMC BIOLOGY (2012)
Why bioimage informatics matters
Gene Myers
NATURE METHODS (2012)
Biological imaging software tools
Kevin W. Eliceiri et al.
NATURE METHODS (2012)
Verteporfin-Based Photodynamic Therapy Overcomes Gemcitabine Insensitivity in a Panel of Pancreatic Cancer Cell Lines
Jonathan P. Celli et al.
LASERS IN SURGERY AND MEDICINE (2011)
Preclinical development of molecular-targeted agents for cancer
Alberto Ocana et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Cell death assays for drug discovery
Oliver Kepp et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Killing Hypoxic Cell Populations in a 3D Tumor Model with EtNBS-PDT
Conor L. Evans et al.
PLOS ONE (2011)
Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer
Imran Rizvi et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Achievements and unmet needs in the management of advanced ovarian cancer
Valentina Guarneri et al.
GYNECOLOGIC ONCOLOGY (2010)
Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model
Jonathan P. Celli et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
Integrin α1β1 Regulates Epidermal Growth Factor Receptor Activation by Controlling Peroxisome Proliferator-Activated Receptor γ-Dependent Caveolin-1 Expression
Xiwu Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Envisioning the future of early anticancer drug development
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2010)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids
Tsung-Ming Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring
W. Zhong et al.
BRITISH JOURNAL OF CANCER (2009)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A gynecologic oncology group study
William E. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Three-dimensional culture models of normal and malignant breast epithelial cells
Genee Y. Lee et al.
NATURE METHODS (2007)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Modelling glandular epithelial cancers in three-dimensional cultures
J Debnath et al.
NATURE REVIEWS CANCER (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
The role of apoptosis in creating and maintaining luminal space with normal and oncogene-expressing mammary acini
J Debnath et al.
CELL (2002)
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
SK Muthuswamy et al.
NATURE CELL BIOLOGY (2001)
Determinants of drug delivery and transport to solid tumors
JLS Au et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study
JI Akahira et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
